Shared epigenetic regulation acting on neuroimmune pathways contributes to the comorbidity between generalized anxiety disorder and COVID-19
Şefayet KaracaiD, Brenda Cabrera‐MendozaiD, Jun He, Dan QiuiD, David DavtianiD, AnnMarie Lacobelle, Yaira Z. Nuñez, John Harrison KrystaliD, Robert H. PietrzakiD, Joel E. GelernteriD, Renato PolimantiiD
Abstract
BackgroundThe biological mechanisms linking generalized anxiety disorder (GAD) and COVID-19 remain poorly understood, despite substantial evidence of their comorbidity. To address this gap, we examined genetic and epigenetic factors underlying their co-occurrence. MethodsIn a multi-ancestry sample of 893 participants, we conducted genome-wide and epigenome-wide analyses of GAD and COVID-19 severity. Integrating large-scale genome-wide datasets and information regarding methylation quantitative trait loci, complementary analytic approaches were used to identify regional methylation patterns, assess genetically regulated DNA methylation in blood and brain tissue, and evaluate causal loci shared between GAD and COVID-19. ResultsGAD was associated with epigenome-wide significant variation in loci involved in chromatin regulation and synaptic signaling. Conversely, COVID-19-related epigenetic signals were enriched in immune-inflammatory and host-response pathways. Mild COVID-19 was epigenetically related to endothelial-inflammatory signals, while severe COVID-19 was linked to epigenetic changes implicated in myeloid and thrombo-inflammatory pathways. Epigenetic signals shared between GAD and COVID-19 implicated processes related to stress adaptation and tissue homeostasis. Genetically informed analyses identified 60 shared loci, including MAPT, ZFP57, and FBXL18, indicating pleiotropy between GAD and COVID-19 in genetically regulated DNA methylation variation. Brain-specific analyses further highlighted convergence in additional loci (i.e., MICB and HLA-DPB1), suggesting neuroimmune mechanisms underlying GAD-COVID-19 shared methylation patterns. ConclusionsThese findings support that GAD and COVID-19 share epigenetic and genetic architecture involving pathways related to vascular integrity, immune function, and cellular adaptation, highlighting a potential neuroimmune basis for their co-occurrence.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Unraveling COVID-19 Relationship with Anxiety Disorders and Symptoms
Zeynep Asgel, Manuela R. Kouakou, … Renato A Polimanti·medRxiv·Jul 21, 2023
- Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder
Abigail ter Kuile, Brittany L. Mitchell, … Thalia Catherine Eley·Molecular PsychiatryPeer-reviewed·Jun 29, 2026
- Identification of Novel Genomic Loci for Anxiety and Extensive Genetic Overlap with Psychiatric Disorders
Markos Tesfaye, Piotr Pawel Jaholkowski, … Ole A. Andreassen·medRxiv·Sep 1, 2023
- Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection
Urs Heilbronner, Fabian Streit, … Eva Christina Schulte·BJPsych OpenPeer-reviewed·Oct 7, 2021
- Reproducible Risk Loci and Psychiatric Comorbidities in Anxiety: Results from ~200,000 Million Veteran Program Participants
Daniel F. Levey, Joel E. Gelernter, … Murray B. Stein·American Journal of PsychiatryPeer-reviewed·Jan 7, 2020
- Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
Nora I. Strom, Brad Verhulst, … Ted Reichborn‐Kjennerud·Nature GeneticsPeer-reviewed·Feb 1, 2026